Furthermore, the fibrotic marker protein TGF-β1 was significantly upregulated following TAC surgery in aged female mice hearts, while GPR30/G1 treatment greatly reduced TGF-β1 expression, implying the inhibition of myocardial fibrosis by GPR30 activation. The gene discussed is GPER1; the disease is Myocardial fibrosis.